We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$775M
AUM Growth
-$436M
Cap. Flow
-$471M
Cap. Flow %
-60.72%
Top 10 Hldgs %
18.21%
Holding
4,545
New
711
Increased
1,179
Reduced
1,568
Closed
1,030

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$8.74M
2
META icon
Meta Platforms (Facebook)
META
+$8.31M
3
AMZN icon
Amazon
AMZN
+$8.08M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$7.61M
5
MSFT icon
Microsoft
MSFT
+$7.1M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$223M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$59.1M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$25.9M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$17.3M
5
SMH icon
VanEck Semiconductor ETF
SMH
+$14.1M

Sector Composition

Rank Sector Weight
1 Financials 11.08%
2 Technology 10%
3 Consumer Discretionary 7.02%
4 Healthcare 6.86%
5 Communication Services 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HBB icon
1376
Hamilton Beach Brands
HBB
$422M
$47K 0.01%
+1,820
New +$58.4K
IMUX icon
1377
Immunic
IMUX
$195M
$47K 0.01%
20
-2
-9% -$4.42K
NATR icon
1378
Nature's Sunshine
NATR
$288M
$47K 0.01%
4,053
+3,074
+314% +$34.9K
NWPX icon
1379
NWPX Infrastructure Inc
NWPX
$1.15B
$47K 0.01%
2,488
+824
+50% +$15.3K
PEN icon
1380
Penumbra
PEN
$12.8B
$47K 0.01%
500
-1,752
-78% -$174K
RARE icon
1381
Ultragenyx Pharmaceutical
RARE
$2.55B
$47K 0.01%
1,011
-1,600
-61% -$78.5K
SMMF
1382
DELISTED
Summit Financial Group, Inc.
SMMF
$47K 0.01%
1,803
+819
+83% +$21.9K
NTUS
1383
DELISTED
Natus Medical Inc
NTUS
$47K 0.01%
1,224
-5,527
-82% -$221K
TSC
1384
DELISTED
TriState Capital Holdings, Inc.
TSC
$47K 0.01%
2,076
-1,087
-34% -$25.3K
UN
1385
DELISTED
Unilever NV New York Registry Shares
UN
$47K 0.01%
830
-4,788
-85% -$276K
CHT icon
1386
Chunghwa Telecom
CHT
$33B
$46K 0.01%
1,292
-1,342
-51% -$46K
CLLS
1387
Cellectis
CLLS
$285M
$46K 0.01%
+1,576
New +$42.9K
DLB icon
1388
Dolby
DLB
$5.79B
$46K 0.01%
+745
New +$45K
EWQ icon
1389
iShares MSCI France ETF
EWQ
$335M
$46K 0.01%
+1,477
New +$45.9K
FRST icon
1390
Primis Financial Corp
FRST
$404M
$46K 0.01%
2,859
+150
+6% +$2.48K
GBLI icon
1391
Global Indemnity Group
GBLI
$46K 0.01%
1,105
+163
+17% +$6.94K
MTRX icon
1392
Matrix Service
MTRX
$335M
$46K 0.01%
2,569
+180
+8% +$2.83K
NVR icon
1393
NVR
NVR
$17B
$46K 0.01%
+13
New +$42.3K
SAM icon
1394
Boston Beer
SAM
$1.92B
$46K 0.01%
240
-899
-79% -$161K
TRIB
1395
Trinity Biotech
TRIB
$8.39M
$46K 0.01%
61
-21
-26% -$16.2K
UVV icon
1396
Universal Corp
UVV
$1.27B
$46K 0.01%
868
-2,014
-70% -$112K
TESS
1397
DELISTED
Tessco Technologies Inc
TESS
$46K 0.01%
2,296
+215
+10% +$3.4K
AIMC
1398
DELISTED
Altra Industrial Motion Corp
AIMC
$46K 0.01%
920
-3,316
-78% -$159K
CXO
1399
DELISTED
CONCHO RESOURCES INC.
CXO
$46K 0.01%
309
-416
-57% -$57.8K
NGHC
1400
DELISTED
National General Holdings Corp
NGHC
$46K 0.01%
+2,322
New +$47.6K
54 55
56
57 58

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2017 Portfolio in Review

As of Q4 2017, Tower Research Capital (TRC) held 4,545 positions worth $775M, down 36% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Tower Research Capital (TRC) withdrew a net $471M in Q4 2017, closing 1,030 positions and reducing 1,568 holdings. Its most notable exit was iShares MSCI EAFE ETF, an estimated $25.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 6.3% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Berkshire Hathaway Class B worth $7.94M.

  • Tower Research Capital (TRC)'s largest Q4 2017 buy was Berkshire Hathaway Class B: 40,072 shares worth $7.94M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2017, an estimated $8.74M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $223M.
  • Tower Research Capital (TRC) fully exited iShares MSCI EAFE ETF in Q4 2017, selling an estimated $25.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 18% of its $775M portfolio in Q4 2017.
  • Tower Research Capital (TRC) opened 711 new positions and closed 1,030 in Q4 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $775M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2017, filed 9 Feb 2018.